KIT and acute myeloid leukemia: In AML patients, leukemic cells express early, hematopoiesis-associated antigens (CD34, CD38, CD117, HLA-DR) and lack markers of myeloid and monocytic maturation (NSE, CD11c, CD14, CD64) [15,22,23,24].